Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Intellia Aktie: FDA-Schub


Die Aktie von Intellia Therapeutics hat seit Jahresbeginn deutlich zugelegt. Auslöser der jüngsten Neubewertung…

Der Beitrag Intellia Aktie: FDA-Schub erschien zuerst auf kapitalmarktexperten.de.


Quelle kapitalmarktexperten.de

Intellia Therapeutics Inc Stock

€11.63
-2.780%
We can see a decrease in the price for Intellia Therapeutics Inc. Compared to yesterday it has lost -€0.330 (-2.780%).
Currently there is a rather positive sentiment for Intellia Therapeutics Inc with 25 Buy predictions and 6 Sell predictions.
With a target price of 25 € there is potential for a 114.96% increase which would mean more than doubling the current price of 11.63 € for Intellia Therapeutics Inc.

Comments